Boston Trust Walden’s Steris STE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.1M | Sell |
307,828
-10,445
| -3% | -$2.56M | 0.56% | 56 |
|
|
2025
Q4 | $80.7M | Sell |
318,273
-5,991
| -2% | -$1.5M | 0.61% | 48 |
|
|
2025
Q3 | $80.2M | Buy |
324,264
+284
| +0.1% | +$68K | 0.59% | 48 |
|
|
2025
Q2 | $77.8M | Buy |
323,980
+67,709
| +26% | +$15.8M | 0.56% | 59 |
|
|
2025
Q1 | $58.1M | Buy |
256,271
+31,530
| +14% | +$6.93M | 0.42% | 86 |
|
|
2024
Q4 | $46.2M | Buy |
224,741
+179,829
| +400% | +$39.5M | 0.32% | 124 |
|
|
2024
Q3 | $10.9M | Buy |
44,912
+118
| +0.3% | +$27.6K | 0.08% | 201 |
|
|
2024
Q2 | $9.83M | Buy |
44,794
+880
| +2% | +$191K | 0.07% | 199 |
|
|
2024
Q1 | $9.87M | Sell |
43,914
-666
| -1% | -$150K | 0.07% | 196 |
|
|
2023
Q4 | $9.8M | Sell |
44,580
-121,561
| -73% | -$25.7M | 0.07% | 194 |
|
|
2023
Q3 | $36.5M | Sell |
166,141
-65,705
| -28% | -$14.9M | 0.31% | 118 |
|
|
2023
Q2 | $52.2M | Sell |
231,846
-11,776
| -5% | -$2.36M | 0.43% | 83 |
|
|
2023
Q1 | $46.6M | Buy |
243,622
+7,479
| +3% | +$1.45M | 0.4% | 88 |
|
|
2022
Q4 | $43.6M | Buy |
236,143
+1,284
| +0.5% | +$226K | 0.38% | 90 |
|
|
2022
Q3 | $39.1M | Sell |
234,859
-1,032
| -0.4% | -$210K | 0.39% | 93 |
|
|
2022
Q2 | $48.6M | Buy |
235,891
+2,521
| +1% | +$568K | 0.46% | 74 |
|
|
2022
Q1 | $56.4M | Buy |
233,370
+5,542
| +2% | +$1.28M | 0.47% | 74 |
|
|
2021
Q4 | $55.5M | Buy |
227,828
+811
| +0.4% | +$185K | 0.45% | 72 |
|
|
2021
Q3 | $46.4M | Buy |
227,017
+14,326
| +7% | +$3.07M | 0.41% | 86 |
|
|
2021
Q2 | $43.9M | Buy |
212,691
+14,144
| +7% | +$2.85M | 0.39% | 91 |
|
|
2021
Q1 | $37.8M | Buy |
198,547
+22,160
| +13% | +$4.11M | 0.37% | 99 |
|
|
2020
Q4 | $33.4M | Buy |
176,387
+3,407
| +2% | +$636K | 0.36% | 93 |
|
|
2020
Q3 | $30.5M | Buy |
172,980
+1,911
| +1% | +$306K | 0.38% | 80 |
|
|
2020
Q2 | $26.2M | Buy |
171,069
+4,393
| +3% | +$669K | 0.35% | 87 |
|
|
2020
Q1 | $23.3M | Buy |
166,676
+5,015
| +3% | +$750K | 0.37% | 80 |
|
|
2019
Q4 | $24.6M | Buy |
161,661
+21,422
| +15% | +$3.14M | 0.29% | 105 |
|
|
2019
Q3 | $20.3M | Buy |
140,239
+10,146
| +8% | +$1.52M | 0.25% | 119 |
|
|
2019
Q2 | $19.4M | Buy |
130,093
+595
| +0.5% | +$79.5K | 0.25% | 119 |
|
|
2019
Q1 | $16.6M | Buy |
129,498
+4,628
| +4% | +$545K | 0.23% | 133 |
|
|
2018
Q4 | $13.3M | Buy |
124,870
+12,250
| +11% | +$1.37M | 0.21% | 135 |
|
|
2018
Q3 | $12.9M | Sell |
112,620
-9,705
| -8% | -$1.1M | 0.18% | 156 |
|
|
2018
Q2 | $12.8M | Buy |
122,325
+6,390
| +6% | +$643K | 0.19% | 154 |
|
|
2018
Q1 | $10.8M | Buy |
115,935
+1,024
| +0.9% | +$93.1K | 0.16% | 174 |
|
|
2017
Q4 | $10.1M | Buy |
114,911
+4,667
| +4% | +$416K | 0.15% | 185 |
|
|
2017
Q3 | $9.75M | Buy |
110,244
+1,439
| +1% | +$122K | 0.15% | 184 |
|
|
2017
Q2 | $8.87M | Buy |
108,805
+15,006
| +16% | +$1.14M | 0.14% | 178 |
|
|
2017
Q1 | $6.51M | Buy |
93,799
+2,436
| +3% | +$169K | 0.1% | 210 |
|
|
2016
Q4 | $6.16M | Buy |
91,363
+5,200
| +6% | +$353K | 0.1% | 209 |
|
|
2016
Q3 | $6.3M | Buy |
86,163
+284
| +0.3% | +$20.1K | 0.1% | 204 |
|
|
2016
Q2 | $5.91M | Sell |
85,879
-696
| -0.8% | -$48.8K | 0.1% | 209 |
|
|
2016
Q1 | $6.15M | Buy |
+86,575
| New | +$5.86M | 0.11% | 206 |
|
|
2015
Q4 | – | Sell |
-660,700
| Closed | -$42.9M | – | 355 |
|
|
2015
Q3 | $42.9M | Sell |
660,700
-21,370
| -3% | -$1.41M | 0.72% | 34 |
|
|
2015
Q2 | $44M | Sell |
682,070
-7,367
| -1% | -$497K | 0.67% | 38 |
|
|
2015
Q1 | $48.4M | Buy |
689,437
+6,718
| +1% | +$443K | 0.72% | 34 |
|
|
2014
Q4 | $44.3M | Buy |
+682,719
| New | +$42.2M | 0.66% | 48 |
|
Other funds holding STE
VCM
VPM
OAG
GIM
Boston Trust Walden's STE Position: Q1 2026 in Review
Boston Trust Walden reduced its Steris (STE) stake by 3.3% in Q1 2026, selling an estimated $2.56M and leaving 307,828 shares worth $68.1M. The position accounts for 0.56% of the portfolio, ranked #56.
Boston Trust Walden first reported a position in STE in Q4 2014 and has held it in 45 quarters since. The position peaked at $80.7M in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.
- Boston Trust Walden held 307,828 shares of Steris worth $68.1M as of Q1 2026.
- Boston Trust Walden sold 10,445 Steris shares in Q1 2026, an estimated $2.56M.
- Steris made up 0.56% of Boston Trust Walden's portfolio in Q1 2026, its #56 holding.
- Boston Trust Walden first reported a position in Steris in Q4 2014 and has held it in 45 quarters since.
- Boston Trust Walden's Steris position peaked at $80.7M in Q4 2025.
- 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.
Based on Boston Trust Walden's 13F filing for Q1 2026, filed 24 Apr 2026.